Frova and Nausea aggravated - a phase IV clinical study of FDA data

Summary:

Nausea aggravated is reported as a side effect among people who take Frova (frovatriptan succinate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Tylenol, and have Asthma.

The phase IV clinical study analyzes which people have Nausea aggravated when taking Frova. It is created by eHealthMe based on reports of 1,941 people who have side effects when taking Frova from the FDA, and is updated regularly.

What is Frova?

Frova has active ingredients of frovatriptan succinate. It is often used in migraine. eHealthMe is studying from 2,100 Frova users. Check the latest studies of Frova.

What is Nausea aggravated?

Nausea aggravated (an urge to vomit) is found to be associated with 3,376 drugs and 1,081 conditions by eHealthMe. Check the latest studies of Nausea aggravated.

On Jul, 05, 2026

1,941 people reported to have side effects when taking Frova.
Among them, 259 people (13.34%) have Nausea aggravated.

Among these 259 people:

* Approximation only. Some reports may have incomplete information.

Do you take Frova and have Nausea aggravated?

- Check whether Nausea aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Frova:

Frova (2,100 reports)

Nausea aggravated treatments and more:

Nausea aggravated (214 reports)

How severe was Nausea aggravated and when was it recovered:

Nausea aggravated in Frova

Expand to all the drugs that have ingredients of frovatriptan succinate:

Nausea aggravated and drugs with ingredients of frovatriptan succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Frova:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea aggravated:

Nausea aggravated (3,376 drugs)

Browse all the conditions that are associated with Nausea aggravated:

Nausea aggravated (1,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on frovatriptan succinate (the active ingredients of Frova) and Frova (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.